MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests an experimental drug called rezpegaldesleukin for adults with moderate-to-severe atopic dermatitis (eczema). About 396 participants will receive either the drug or a placebo for 16 weeks, and those who respond may continue treatment for up to a year. The goal is …
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
New shot for eczema shows promise in large trial
Disease control OngoingThis study tests an experimental injection called SHR-1819 for adults with moderate to severe atopic dermatitis (eczema). The goal is to see if it can clear skin rashes and reduce itching better than a placebo. 652 participants are taking part in this Phase 3 trial, which is the …
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 22, 2026 13:54 UTC